Cited by 3,009Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Health and Risk FactorsLipoproteins and Cardiovascular Health

The Metabolic Syndrome and Cardiovascular Risk

Open access
Mottillo, Salvatore, Filion, Kristian B., Genest, Jacques, Joseph, Lawrence, Pilote, Louise, Poirier, Paul, Rinfret, Stéphane, Schiffrin, Ernesto L. +1 more·2010·Journal of the American College of Cardiology

Abstract

Objectives We sought to conduct a systematic review and meta-analysis of the cardiovascular risk associated with the metabolic syndrome as defined by the 2001 National Cholesterol Education Program (NCEP) and 2004 revised National Cholesterol Education Program (rNCEP) definitions.Background Numerous studies have investigated the cardiovascular risk associated with the NCEP and rNCEP definitions of the metabolic syndrome. There is debate regarding the prognostic significance of the metabolic syndrome for cardiovascular outcomes.Methods We searched the Cochrane Library, EMBASE, and Medline databases through June 2009 for prospective observational studies investigating the cardiovascular effects of the metabolic syndrome. Two reviewers extracted data, which were aggregated using random-effects models.Results We identified 87 studies, which included 951,083 patients (NCEP: 63 studies, 497,651 patients; rNCEP: 33 studies, 453,432 patients). There was little variation between the cardiovascular risk associated with NCEP and rNCEP definitions. When both definitions were pooled, the metabolic syndrome was associated with an increased risk of cardiovascular disease (CVD) (relative risk [RR]: 2.35; 95% confidence interval [CI]: 2.02 to 2.73), CVD mortality (RR: 2.40; 95% CI: 1.87 to 3.08), all-cause mortality (RR: 1.58; 95% CI: 1.39 to 1.78), myocardial infarction (RR: 1.99; 95% CI: 1.61 to 2.46), and stroke (RR: 2.27; 95% CI: 1.80 to 2.85). Patients with the metabolic syndrome, but without diabetes, maintained a high cardiovascular risk.Conclusions The metabolic syndrome is associated with a 2-fold increase in cardiovascular outcomes and a 1.5-fold increase in all-cause mortality. Studies are needed to investigate whether or not the prognostic significance of the metabolic syndrome exceeds the risk associated with the sum of its individual components. Furthermore, studies are needed to elucidate the mechanisms by which the metabolic syndrome increases cardiovascular risk.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2010.05.034

Cites

118 of 118 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • People with MetS have a 2-fold increase in CV outcomes and a 1.5-fold increase in all-cause mortality.

    “Data from recent meta-analyses indicate that people with MetS have a 2-fold increase in CV outcomes and 1.5-fold increase in all-cause mortality.168”

    From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [168]

  • Recent meta-analyses indicate people with MetS have a two-fold increase in CV outcomes and a 1.5-fold increase in all-cause mortality.

    “Data from recent meta-analyses indicate that people with MetS have a two-fold increase in CV outcomes and a 1.5-fold increase in all-cause mortality. 348”

    From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [348]

  • Metabolic syndrome identifies people at higher risk of CVD than the general population.

    “MetS identifies people at a higher risk of CVD than the general population.”

    From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [348]

  • Data from recent meta-analyses indicate that people with metabolic syndrome have a two-fold increase in cardiovascular outcomes and a 1.5-fold increase in all-cause mortality.

    “Data from recent meta-analyses indicate that people with MetS have a two-fold increase in CV outcomes and a 1.5fold increase in all-cause mortality.348”

    From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [348]

  • Metabolic syndrome is a condition that poses a high risk for the development of cardiovascular disease.

    “[Statement]Metabolic syndrome is a condition that poses a high risk for the development of cardiovascular disease (Evidence level: E-1b).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. WHO Consultation. Definition, diagnosis and classification of dia- betes mellitus and its complications. Geneva, Switzerland: World Health Organization; 1999:31-3.
  2. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE study. Eur J Cardiovasc Prev Rehabil 2007;14:192-9.

Cited by

Sorted by citations

Authors
Mottillo, S., Filion, K. B., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Schiffrin, E. L., & Eisenberg, M. J.
Affiliations
  • Jewish General Hospital (CA)
  • McGill University Health Centre (CA)
  • Institut universitaire de cardiologie et de pneumologie de Québec (CA)
Corresponding author
Eisenberg, Mark J.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2010-09
Volume
56
Issue
14
Pages
1113-1132
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2129448542
Cited by
3,009
References
118
Citations by year
2026: 168 · 2025: 198 · 2024: 235 · 2023: 255 · 2022: 219 · 2021: 201 · 2020: 225 · 2019: 197 · 2018: 178 · 2017: 138 · 2016: 182 · 2015: 179 · 2014: 181 · 2013: 189 · 2012: 155
FWCI
108.60
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Canadian Institutes of Health Research (82918)
  • CIHR Team Grant in Cardiovascular Outcomes Research
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
Keywords
metabolic syndrome, cardiovascular risk, cardiovascular mortality, myocardial infarction, stroke, all-cause mortality, NCEP criteria, diabetes mellitus, prognostic value
MeSH terms
Cardiovascular Diseases, Cause of Death, Coronary Disease, Female, Humans, Male, Severity of Illness Index, Comorbidity, Prevalence, Survival Analysis, Risk Assessment, Stroke, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review